-
公开(公告)号:EP3092306A1
公开(公告)日:2016-11-16
申请号:EP15700128.0
申请日:2015-01-09
申请人: Sirion Biotech GmbH , Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH)
IPC分类号: C12N7/00 , C12N15/867 , C07K14/145
摘要: The present invention relates to a nucleic acid molecule comprising or consisting of a nucleic acid sequence encoding the vesicular stomatitis virus envelope glycoprotein (VSV-G) linked to a (poly)peptide comprising or consisting of a cell membrane-binding domain, said nucleic acid sequence comprising in 5′ to 3′ direction (a) a first sequence segment encoding an endoplasmic reticulum (ER) signal sequence; (b) a second sequence segment encoding said (poly)peptide comprising or consisting of a cell membrane-binding domain; (c) a third sequence segment encoding a linker; and (d) a fourth sequence segment encoding said VSV-G. Further, the invention relates to a vector comprising the nucleic acid molecule of the invention, a host cell comprising said vector or nucleic acid molecule, the polypeptide encoded by said nucleic acid molecule and a method of producing the polypeptide encoded by said nucleic acid molecule. In addition, the invention relates to a pseudotyped lentiviral vector particle, a method of transducing a cell as well as a kit comprising various combinations of the nucleic acid molecule, vectors, polypeptides and host cells of the invention.
-
公开(公告)号:EP4151738A1
公开(公告)日:2023-03-22
申请号:EP22204240.0
申请日:2013-02-28
申请人: Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) , Sirion Biotech GmbH
IPC分类号: C12N15/867 , A61K48/00
摘要: The present invention relates to a method for transducing a target cell, the method comprising the step of contacting a target cell with a retroviral vector and a poloxamer having a molecular weight of 12,8 kDa to about 15 kDa. Further, the invention relates to the use of a poloxamer as defmed herein, optionally in combination with a polycationic substance as defmed herein, for transducing a target cell with a retroviral vector and a kit comprising a retroviral vector, a poloxamer as defined herein and, option ally, instructions for use.
-
公开(公告)号:EP3763820A1
公开(公告)日:2021-01-13
申请号:EP20188488.9
申请日:2013-02-28
申请人: Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) , Sirion Biotech GmbH
IPC分类号: C12N15/867 , A61K48/00
摘要: The present invention relates to a method for transducing a target cell, the method comprising the step of contacting a target cell with a retroviral vector and a poloxamer having a molecular weight of 12,8 kDa to about 15 kDa. Further, the invention relates to the use of a poloxamer as defined herein, optionally in combination with a polycationic substance as defined herein, for transducing a target cell with a retroviral vector and a kit comprising a retroviral vector, a poloxamer as defined herein and, optionally, instructions for use.
-
公开(公告)号:EP2820138B1
公开(公告)日:2020-10-28
申请号:EP13706283.2
申请日:2013-02-28
申请人: Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) , Sirion Biotech GmbH
IPC分类号: C12N15/867 , A61K48/00
-
公开(公告)号:EP3868888A1
公开(公告)日:2021-08-25
申请号:EP21163635.2
申请日:2013-02-28
申请人: Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) , Sirion Biotech GmbH
IPC分类号: C12N15/867 , A61K48/00
摘要: The present invention relates to a method for transducing a target cell, the method comprising the step of contacting a target cell with a retroviral vector and a poloxamer having a molecular weight of 12,8 kDa fo about 15 kDa. Further, the invention relates to the use of a poloxamer as defmed herein, optionally in combination with a polycationic substance as defmed herein, for transducing a target cell with a retroviral vector and a kit comprising a retroviral vector, a poloxamer as defined herein and, option ally, instructions for use.
-
公开(公告)号:EP3670651A1
公开(公告)日:2020-06-24
申请号:EP19202980.9
申请日:2015-01-09
申请人: Sirion Biotech GmbH , Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt GmbH
IPC分类号: C12N7/00 , C12N15/867 , C07K14/145 , C07K16/28
摘要: The present invention relates to a nucleic acid molecule comprising or consisting of a nucleic acid sequence encoding the vesicular stomatitis virus envelope glycoprotein (VSV-G) linked to a (poly)peptide comprising or consisting of a cell membrane-binding domain, said nucleic acid sequence comprising in 5' to 3' direction (a) a first sequence segment encoding an endoplasmic reticulum (ER) signal sequence; (b) a second sequence segment encoding said (poly)peptide comprising or consisting of a cell membrane-binding domain; (c) a third sequence segment encoding a linker; and (d) a fourth sequence segment encoding said VSV-G. Further, the invention relates to a vector comprising the nucleic acid molecule of the invention, a host cell comprising said vector or nucleic acid molecule, the polypeptide encoded by said nucleic acid molecule and a method of producing the polypeptide encoded by said nucleic acid molecule. In addition, the invention relates to a pseudotyped lentiviral vector particle, a method of transducing a cell as well as a kit comprising various combinations of the nucleic acid molecule, vectors, polypeptides and host cells of the invention.
-
公开(公告)号:EP3092306B1
公开(公告)日:2019-10-16
申请号:EP15700128.0
申请日:2015-01-09
申请人: Sirion Biotech GmbH , Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH)
IPC分类号: C12N7/00 , C12N15/867 , C07K14/145
-
公开(公告)号:EP2820138A1
公开(公告)日:2015-01-07
申请号:EP13706283.2
申请日:2013-02-28
申请人: Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) , Sirion Biotech GmbH
IPC分类号: C12N15/867 , A61K48/00
摘要: The present invention relates to a method for transducing a target cell, the method comprising the step of contacting a target cell with a retroviral vector and a poloxamer having a molecular weight of 12.8 kDa to about 15 kDa. Further, the invention relates to the use of a poloxamer as defined herein, optionally in combination with a polycationic substance as defined herein, for transducing a target cell with a retroviral vector and a kit comprising a retroviral vector, a poloxamer as defined herein and, optionally, instructions for use.
摘要翻译: 本发明涉及一种转导靶细胞的方法,所述方法包括使靶细胞与逆转录病毒载体和分子量为12.8kDa至约15kDa的泊洛沙姆接触的步骤。 此外,本发明涉及如本文所定义的泊洛沙姆,任选地与本文定义的聚阳离子物质组合用于用逆转录病毒载体转导靶细胞的用途,以及包含逆转录病毒载体,本文定义的泊洛沙姆的试剂盒, 可选择使用说明书。
-
-
-
-
-
-
-